Cathie Wood Stock Portfolio: 5 Newest Stock Picks This Year

4. Senti Biosciences, Inc. (NASDAQ:SNTI)

Ark Investment’s Stake Value: $4.5 million

Percentage of Ark Investment’s 13F Portfolio: 0.03%

Number of Hedge Fund Holders: 2

Senti Biosciences, Inc. (NASDAQ:SNTI) is a biotechnology company that develops gene therapies. These target diseases such as leukemia, carcinoma, and cancer cells. It is headquartered in South San Francisco, California.

Chardan Capital Markets set a $12 share price target for Senti Biosciences, Inc. (NASDAQ:SNTI) in September 2022, as it shared that the firm’s products can address several key concerns present with current gene therapies. The company’s latest earnings report saw it post $1.36 million in revenue for a strong 72% annual growth and -$0.86 in GAAP earnings per share.

Ark Investment’s third quarter investment portfolio saw the firm add two million Senti Biosciences, Inc. (NASDAQ:SNTI) shares which were worth $4.5 million. By the end of this year’s second quarter, two out of the 895 hedge funds polled by Insider Monkey had invested in the company.